Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Ireland

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Pharmacology|October 1, 1987
Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglionS J Ireland, C C Jordan
Journal of American College Health : J of ACH|January 1, 1997
HIV/AIDS risk in heterosexual college students. A review of a decade of literatureJ E Lewis, R M Malow, S J Ireland
British Journal of Pharmacology|January 1, 1987
Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglionS J Ireland, D W Straughan, M B Tyers
Neuroscience|January 1, 1992
Characterization of tachykinin-induced ventral root depolarization in the neonatal rat isolated spinal cordS J Ireland, I K Wright, C C Jordan
Psychiatric Services (Washington, D.C.)|November 1, 1996
Alcohol & drug abuse. HIV infection and risky sexual behaviors among women in treatment for noninjection drug dependenceR M Malow, K B Jager, S J Ireland, et al.
Neuroscience|January 1, 1992
Ontogeny and characterization of [125I]Bolton Hunter-eledoisin binding sites in rat spinal cord by quantitative autoradiographyI J Beresford, S J Ireland, J Stables, et al.
Biochemical Pharmacology|October 20, 1992
Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptorsL P Davies, G B Barlin, S J Ireland, et al.
British Journal of Pharmacology|October 1, 1991
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345I J Beresford, P J Birch, R M Hagan, et al.
Journal of Pharmaceutical Sciences|December 1, 1991
Lipidic peptides. III: Lipidic amino acid and oligomer conjugates of morphineR A Hughes, I Toth, P Ward, et al.
British Journal of Pharmacology|June 1, 1988
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptorsA Butler, J M Hill, S J Ireland, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Pharmacology|October 1, 1987
Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglionS J Ireland, C C Jordan
Journal of American College Health : J of ACH|January 1, 1997
HIV/AIDS risk in heterosexual college students. A review of a decade of literatureJ E Lewis, R M Malow, S J Ireland
British Journal of Pharmacology|January 1, 1987
Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglionS J Ireland, D W Straughan, M B Tyers
Neuroscience|January 1, 1992
Characterization of tachykinin-induced ventral root depolarization in the neonatal rat isolated spinal cordS J Ireland, I K Wright, C C Jordan
Psychiatric Services (Washington, D.C.)|November 1, 1996
Alcohol & drug abuse. HIV infection and risky sexual behaviors among women in treatment for noninjection drug dependenceR M Malow, K B Jager, S J Ireland, et al.
Neuroscience|January 1, 1992
Ontogeny and characterization of [125I]Bolton Hunter-eledoisin binding sites in rat spinal cord by quantitative autoradiographyI J Beresford, S J Ireland, J Stables, et al.
Biochemical Pharmacology|October 20, 1992
Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptorsL P Davies, G B Barlin, S J Ireland, et al.
British Journal of Pharmacology|October 1, 1991
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345I J Beresford, P J Birch, R M Hagan, et al.
Journal of Pharmaceutical Sciences|December 1, 1991
Lipidic peptides. III: Lipidic amino acid and oligomer conjugates of morphineR A Hughes, I Toth, P Ward, et al.
British Journal of Pharmacology|June 1, 1988
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptorsA Butler, J M Hill, S J Ireland, et al.
Pageof 4